UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 527

Sortiert nach

Serial combination of non‐invasive tools improves the diagnostic accuracy of severe liver fibrosis in patients with NAFLD

Alimentary pharmacology & therapeutics, 2017-09, Vol.46 (6), p.617-627

2017

Volltextzugriff (PDF)

Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study

Gut, 2006-03, Vol.55 (3), p.403-408

2006

Volltextzugriff (PDF)

Non‐invasive tests for fibrosis and liver stiffness predict 5‐year survival of patients chronically infected with hepatitis B virus

Alimentary pharmacology & therapeutics, 2013-05, Vol.37 (10), p.979-988

2013

Volltextzugriff (PDF)

Transient elastography and biomarkers for liver fibrosis assessment and follow‐up of inactive hepatitis B carriers

Alimentary pharmacology & therapeutics, 2011-02, Vol.33 (4), p.455-465

2011

Volltextzugriff (PDF)

Variability of the area under the receiver operating characteristic curves in the diagnostic evaluation of liver fibrosis markers: impact of biopsy length and fragmentation

Alimentary pharmacology & therapeutics, 2007-03, Vol.25 (6), p.733-739

2007

Volltextzugriff (PDF)

The malignant transformation of hepatocellular adenoma: experience of a French liver center

Journal of hepatology, 2017, Vol.66 (1), p.S219-S220

2017

Volltextzugriff (PDF)

The combination of Fibroscan with blood markers in the fibrometerVCTE significantly reduces the use of liver biopsy for the assessment of advanced fibrosis in non-alcoholic fatty liver disease

Journal of hepatology, 2017, Vol.66 (1), p.S161-S162

2017

Volltextzugriff (PDF)

Reliability criteria for the diagnosis of fatty liver using controlled attenuation parameter by transient elastography – A multicentre study of 754 patients

Journal of hepatology, 2017, Vol.66 (1), p.S67-S68

2017

Volltextzugriff (PDF)

Serial combination of noninvasive tools improves the diagnostic accuracy of severe liver fibrosis in patients with nonalcoholic fatty liver disease

Journal of hepatology, 2017, Vol.66 (1), p.S591-S591

2017

Volltextzugriff (PDF)

ASS1 immunohistochemistry identifies unclassified hepatocellular adenoma. Experience of a single French liver center

Journal of hepatology, 2017, Vol.66 (1), p.S617-S617

2017

Volltextzugriff (PDF)

Association of Helicobacter species with hepatitis C cirrhosis with or without hepatocellular carcinoma

Gut, 2005-03, Vol.54 (3), p.396-401

2005

Volltextzugriff (PDF)

Inflammatory syndrome with liver adenomatosis: the beneficial effects of surgical management

Gut, 2007-02, Vol.56 (2), p.307-309

2007

Volltextzugriff (PDF)

Protection enhancement strategies of potential outbreaks during Hajj

American journal of disaster medicine, 2024, Vol.19 (1), p.71

2024

Volltextzugriff (PDF)

Serial combination of noninvasive tools improves the diagnostic accuracy of severe liver fibrosis in patients with nonalcoholic fatty liver disease

Digestive and liver disease, 2017-02, Vol.49 (1), p.e2-e2

2017

Volltextzugriff (PDF)

P0989 : A combination of elastometry and blood markers improves the non-invasive staging of liver fibrosis in NAFLD

Journal of hepatology, 2015-04, Vol.62, p.S717-S718

2015

Volltextzugriff (PDF)

Nosology and Molecular Classification of Hepatocellular Adenomas

Journal of hepatology, 2016, Vol.64 (2), p.S160-S160

2016

Volltextzugriff (PDF)

995 SORAFENIB IN THE PALLIATIVE TREATMENT OF HEPATOCELLULAR CARCINOMA (HCC) DEVELOPED IN NON-FIBROTIC LIVER (F0-F1): SAFETY, EFFICACY. SINGLE-CENTER SERIE OF 33 CASES

Journal of hepatology, 2012-04, Vol.56, p.S389-S389

2012

Volltextzugriff (PDF)

996 PREDICTIVE FACTORS OF RESPONSE TO SORAFENIB IN HEPATOCELLULAR CARCINOMA: A RETROSPECTIVE PILOT STUDY

Journal of hepatology, 2012-04, Vol.56, p.S390-S390

2012

Volltextzugriff (PDF)

631 HEPATOCELLULAR CARCINOMA (HCC) AND METABOLIC SYNDROME: CLINICAL, BIOLOGICAL, PATHOLOGICAL FEATURES AND PROGNOSIS. ANALYSIS OF A PROSPECTIVE COHORT OF 925 HCC

Journal of hepatology, 2013-04, Vol.58, p.S257-S258

2013

Volltextzugriff (PDF)

Hepatic steatosis in HIV‐HCV coinfected patients in France: comparison with HCV monoinfected patients matched for body mass index and HCV genotype

Alimentary Pharmacology and Therapeutics, 2007-12, Vol.26 (11‐12), p.1489-1498

2007

Volltextzugriff (PDF)

958 DIAGNOSIS OF BENIGN HEPATOCELLULAR TUMORS/VALUE OF A SIMPLE ALGORITHM BASED ON SPECIFIC HISTOCHEMICAL MARKERS PERFORMED ON LIVER BIOPSIES, COMPARED WITH SURGICAL SPECIMEN

Journal of hepatology, 2011-03, Vol.54, p.S383-S383

2011

Volltextzugriff (PDF)

327 XL PROBE OF FIBROSCAN® IN PATIENTS WITH CHRONIC LIVER DISEASE. A PROSPECTIVE EVALUATION IN COMPARISON WITH LIVER BIOPSY, M PROBE, FIBROTEST AND APRI

Journal of hepatology, 2011-03, Vol.54, p.S131-S131

2011

Volltextzugriff (PDF)

21 NON INVASIVE DIAGNOSIS OF STEATOSIS USING CAP BY FIBROSCAN®. A PROSPECTIVE STUDY

Journal of hepatology, 2011-03, Vol.54, p.S10-S10

2011

Volltextzugriff (PDF)

Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C

Gastroenterology (New York, N.Y. 1943), 2005-02, Vol.128 (2), p.343-350

2005

Volltextzugriff (PDF)

Argininosuccinate synthase 1 (ASS1): A marker of unclassified hepatocellular adenoma and high bleeding risk

Hepatology (Baltimore, Md.), 2017-12, Vol.66 (6), p.2016-2028

2017

Volltextzugriff (PDF)

1 – 25 von 527

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(446)
Mit Volltextzugriff
(468)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(262)
Life Sciences & Biomedicine
(216)
Humans
(162)
Female
(112)
Biological And Medical Sciences
(98)
Male
(91)
Middle Aged
(77)
Medical Sciences
(74)
Adult
(72)
Life Sciences
(54)
Physiology
(51)
Biochemistry & Molecular Biology
(50)
Freshwater
(50)
Gastroenterology & Hepatology
(50)
Fisheries
(48)
Aged
(43)
Physical Sciences
(38)
Marine
(35)
Gastroenterology. Liver. Pancreas. Abdomen
(33)
Animals
(31)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Serial combination of non‐invasive tools improves the diagnostic accuracy of severe liver fibrosis in patients with NAFLD

Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study

Non‐invasive tests for fibrosis and liver stiffness predict 5‐year survival of patients chronically infected with hepatitis B virus

Transient elastography and biomarkers for liver fibrosis assessment and follow‐up of inactive hepatitis B carriers

Variability of the area under the receiver operating characteristic curves in the diagnostic evaluation of liver fibrosis markers: impact of biopsy length and fragmentation

The malignant transformation of hepatocellular adenoma: experience of a French liver center

The combination of Fibroscan with blood markers in the fibrometerVCTE significantly reduces the use of liver biopsy for the assessment of advanced fibrosis in non-alcoholic fatty liver disease

Reliability criteria for the diagnosis of fatty liver using controlled attenuation parameter by transient elastography – A multicentre study of 754 patients

Serial combination of noninvasive tools improves the diagnostic accuracy of severe liver fibrosis in patients with nonalcoholic fatty liver disease

ASS1 immunohistochemistry identifies unclassified hepatocellular adenoma. Experience of a single French liver center

Association of Helicobacter species with hepatitis C cirrhosis with or without hepatocellular carcinoma

Inflammatory syndrome with liver adenomatosis: the beneficial effects of surgical management

Protection enhancement strategies of potential outbreaks during Hajj

Serial combination of noninvasive tools improves the diagnostic accuracy of severe liver fibrosis in patients with nonalcoholic fatty liver disease

P0989 : A combination of elastometry and blood markers improves the non-invasive staging of liver fibrosis in NAFLD

Nosology and Molecular Classification of Hepatocellular Adenomas

995 SORAFENIB IN THE PALLIATIVE TREATMENT OF HEPATOCELLULAR CARCINOMA (HCC) DEVELOPED IN NON-FIBROTIC LIVER (F0-F1): SAFETY, EFFICACY. SINGLE-CENTER SERIE OF 33 CASES

996 PREDICTIVE FACTORS OF RESPONSE TO SORAFENIB IN HEPATOCELLULAR CARCINOMA: A RETROSPECTIVE PILOT STUDY

631 HEPATOCELLULAR CARCINOMA (HCC) AND METABOLIC SYNDROME: CLINICAL, BIOLOGICAL, PATHOLOGICAL FEATURES AND PROGNOSIS. ANALYSIS OF A PROSPECTIVE COHORT OF 925 HCC

Hepatic steatosis in HIV‐HCV coinfected patients in France: comparison with HCV monoinfected patients matched for body mass index and HCV genotype

958 DIAGNOSIS OF BENIGN HEPATOCELLULAR TUMORS/VALUE OF A SIMPLE ALGORITHM BASED ON SPECIFIC HISTOCHEMICAL MARKERS PERFORMED ON LIVER BIOPSIES, COMPARED WITH SURGICAL SPECIMEN

327 XL PROBE OF FIBROSCAN® IN PATIENTS WITH CHRONIC LIVER DISEASE. A PROSPECTIVE EVALUATION IN COMPARISON WITH LIVER BIOPSY, M PROBE, FIBROTEST AND APRI

21 NON INVASIVE DIAGNOSIS OF STEATOSIS USING CAP BY FIBROSCAN®. A PROSPECTIVE STUDY

Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C

Argininosuccinate synthase 1 (ASS1): A marker of unclassified hepatocellular adenoma and high bleeding risk

Suchergebnisse filtern